Most of the diseases which plague humankind today are multifactorial: they are not simply the result of one mutation in one gene, producing one rogue protein that can no longer carry out its job. Diabetes and obesity, for instance, depend on many simultaneous genetic and environmental factors.
Similarly, in biotechnology, processes cannot be optimised by simply changing one component of a complex process. It is the networks of interaction that Systems Biology, the study of how biological networking produces function at the level of the cell, organ and body, focuses on. The idea is that once we know which networks are fired in health, and misfired in disease, we will know how to fix the consequences of misfires by treating networks rather than just component molecules.
The situation is much like that of hooliganism in a soccer stadium, explains Professor Hans Westerhoff, who splits his time between the Manchester Centre for Integrative Systems Biology, Manchester, U.K. and the Netherlands’ Institute for Systems Biology in Amsterdam and is a member of the ESF Task Force. If one person – or molecule – incites a person who then incites the next, then the whole crowd will misbehave. To deal with this, one should moderate the network, by making sure the individuals are too far apart to interact.
Systems Biology requires the integration of precise mathematical and experimental approaches, in ways and to extents that are new to mainstream Biology and Medicine. Europe leads in most of these individual approaches, but Systems Biology of any particular disease requires the simultaneous study of all the links in huge networks, and the best scientists for each of the different links are in different European countries.
For Europe to take its lead in the research of Systems Biology, the continent needs to establish an interactive network itself, meaning that nations should not independently address their own parts of the ‘grand challenge’ of Systems Biology. A paradigm shift is needed therefore, away from isolated, country-based, molecular biology and physiology, to extensive and intensive networks of excellent scientists across Europe.
The European Science Foundation (ESF) Task Force, comprising of nine experts in the field, has published a series of recommendations build on the ESF Forward Look report Systems Biology: a Grand Challenge for Europe . In their Strategic Guidance and Recommendations they set out a road map to establish a pioneering Systems Biology research programme in Europe. Based on the advice given by the Task Force the next steps will be to start actual discussions among the ESF’s 75 Member Organisations, the Commission and other actors in the field, both public and private, on how to go forward.
The vision is that Europe will take the lead in making a ‘blue cell’ — a generic, model blueprint of a cell — and then fill out the blueprint with information for a number of important diseases and biotechnological processes.
One prerequisite for this is new, much more quantitative, and biology-specific technology. A massive initiative is needed to develop the kinds of advanced technology that can look at networks in cells, clusters of cells, organs and bodies.
“We cannot move forward in Systems Biology in Europe unless we have the technology to back up our vision,” says Professor Rudolf Aebersold from the Institute of Molecular Systems Biology at ETH in Zurich, Switzerland, and a member of the ESF Task Force. “We need new, powerful, user-friendly technologies not only to process and integrate large amounts of data, enhance data sharing and visualise models of biological systems, but also to collect that data in the first place.”
Though the ultimate goal is applying Systems Biology to human health, to begin with it is likely that technology will also be developed and tested in smaller organisms and then scaled up to humans. Equally, the Task Force recommends that to begin with, particular topics on a common theme are chosen, such as cancer or obesity, and generic technology is produced that can then be applied to other areas.
To organise research in Europe, the Task Force recommends dividing funded research into two sub-themes: Systems Biotechnology and Multifactorial Diseases. These should be connected to, and incorporate, existing research programmes in Europe.
To achieve these goals, a massive workforce from many difference disciplines will be needed.
“We need scientists that can understand both sides of the Systems Biology coin: biologists that can handle equations and physical scientists that know their way around in experimental biology,” says Professor Westerhoff. “The Task Force recommends that more support is given to existing Systems Biology training and exchange programmes so that scientists from other disciplines are attracted to our field.”
The Europe-wide network will also need ‘hubs’; European reference laboratories allowing any researcher to conduct high quality research, even if their home institution cannot support it. These should also distribute standard experimental procedures, samples and datasets to ensure that everyone in the network is working in the same way. Similarly, Institutes of Advanced Studies should be established to host short-duration, focused programmes for researchers from across Europe.
The Task force has also suggested the ESF should support the overseeing of this network by continuing to support and host the establishment of a consortium of interested parties and support a European Systems Biology Office.Recommendations
The task force will then:
Initiate, coordinate and fund a single GRand Action on Systems Biology (GRASB), consisting of activities working towards the integral ‘Networks for Life’ project and become the world’s largest, best integrated, hence most effective Systems Biology programme.
Call for applications and expressions of interest in developing technology for and in carrying out world-leading Systems Biology research; a network of research on Systems Biotechnology; a network of research on multifactorial disease; a network of training activities; a network of European Reference Laboratories; and one or two Centres for Advanced Studies.
Organise workshops to ensure activities are kept up to date.
Develop a programme for GRASB, including funding mechanisms.
Define ways of disseminating strategies for all GRASB activities.
Thomas Lau | European Science Foundation
‘Farming’ bacteria to boost growth in the oceans
24.10.2016 | Max-Planck-Institut für marine Mikrobiologie
Calcium Induces Chronic Lung Infections
24.10.2016 | Universität Basel
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
24.10.2016 | Earth Sciences
24.10.2016 | Life Sciences
24.10.2016 | Physics and Astronomy